EODData

MEMBERSHIP REGISTER LOG IN

LSE, TRX: Tissue Regenix Group PLC

24 Oct 2025
LAST:

7.250

CHANGE:
 0.00		OPEN:
7.250		HIGH:
7.500		ASK:
19.000		VOLUME:
102.2K
CHG(%):
0.00		PREV:
7.250		LOW:
7.000		BID:
16.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
24 Oct 257.2507.5007.0007.250102.2K
23 Oct 257.2507.5007.0007.250102.2K
22 Oct 257.2507.5007.0007.250102.2K
21 Oct 257.1707.5007.0007.250350.8K
20 Oct 258.1509.0007.0007.250480.4K
17 Oct 258.7409.0008.0009.0001.94M
16 Oct 256.0009.0004.7709.0001.62M
15 Oct 258.2409.3407.8009.000681.0K
14 Oct 258.5008.5007.5008.000213.5K
13 Oct 257.9958.5007.5008.000313.2K

COMPANY PROFILE

Name:Tissue Regenix Group PLC
About:Tissue Regenix Group plc, a medical technology company, develops and commercializes platform technologies for bone graft substitutes, skin, and soft tissue biologics markets in the United States and internationally. The company operates in two segments, dCELL and BioRinse. It offers dCELL technology, a soft tissue decellularisation process that removes DNA and other cellular material from animal and human soft tissue to repair diseased or damaged body parts; and BioRinse technology, a technology that natural bone filler solution for osteoinductivity to stimulate and regenerate native bone growth. The company provides DermaPure, a decellularised dermal allograft that provides soft tissue with supplemental support, reinforcement, and/or protection from mechanical stress. In addition, it offers OrthoPure XT, provides biomechanically appropriate tissue scaffold for cellular repopulation and eventual regeneration; ConCelltrate 100, a verified osteoinductive bone matrix; MatrixCellect 100, a demineralised bone matrix (DBM) for orthopaedic; Matrix IQ Dermis, a human-derived dermal graft which is decellularised to remove cellular components and preserve the biological properties that promote revascularisation, repair, and augmentation of damaged tissue; and Matrix OI FlexIt, a thin pliable demineralised cortical allograft bone sheet. Further, it provides offers DentalFix, a mineralized particulate allograft that offer osteoconductive properties of natural bone; Matrix OI 100 DBM for non-structural bone-grafting; Matrix OI Strips and Blocks, a stem cell containment human scaffold; AmnioWorks to optimise membrane defects; and sports medicine products. Tissue Regenix Group plc was incorporated in 2006 and is based in Garforth, the United Kingdom.
Sector:Healthcare
Industry:Biotechnology
Address:Phoenix Court, Garforth, United Kingdom, LS25 2GY
Website:https://www.tissueregenix.com
ISIN:GB00B5SGVL29
LEI:213800PNOD5UHQUFJI36

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

TECHNICAL INDICATORS

MA5:7.250.0%
MA10:7.939.3%
MA20:9.5732.1%
MA50:19.79173.0%
MA100:25.51251.9%
MA200:33.68364.6%
RSI14:23.85 
WPR14:-100.00 
MTM14:-1.88
ROC14:-0.21 
ATR:1.23 
Week High:9.0024.1%
Week Low:7.003.6%
Month High:24.00231.0%
Month Low:4.77364.6%
Year High:66.00810.3%
Year Low:4.7752.0%

RECENT SPLITS

Date Ratio
28 Apr 20231-100
29 Jun 20101-5